Exercise capacity in patients with β-thalassaemia intermedia

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Thalassaemia intermedia patients can suffer fatigue and exercise capacity reduction, possibly because of anaemia, deconditioning and lack of exercise-induced haemoconcentration. We studied 21 β-thalassaemia intermedia patients, 10 splenectomised (group A) and 11 not splenectomised (group B). Patients were evaluated by cardiopulmonary exercise test with blood sampling for haemoglobin and plasma protein measurements at rest and peak. During exercise, an isolated increase of haemoglobin suggested spleen contraction while a parallel increase of haemoglobin and proteins suggested fluid filtration through capillary wall. Groups were homogeneous for age and gender. Peak oxygen consumption (VO2) was 22.5 ± 4.4 ml/min/kg (51 ± 14%) and 24.3 ± 7.0 (53 ± 12%) in groups A and B respectively [not significant (NS)]. At rest, haemoglobin was 8.8 g/dl in both groups. Exercise-induced increment was 0.4 ± 0.2 and 1.0 ± 0.4 g/dl (P <0.001) for haemoglobin and 4.0 ± 3.0 and 5.0 ± 4.0 g/l (NS) for proteins, in groups A and B respectively. Anaemia was the major cause of peak VO2 reduction (1097 ± 260 ml/min). However, anaemia did not explain the entire exercise capacity reduction, suggesting the presence of muscular deconditioning. Exercise capacity is reduced in β-thalassaemia intermedia because of anaemia and muscular deconditioning. Spleen contraction does not significantly influence exercise capacity although exercise-induced haemoconcentration was greater in patients with spleen.

Original languageEnglish
Pages (from-to)278-281
Number of pages4
JournalBritish Journal of Haematology
Volume131
Issue number2
DOIs
Publication statusPublished - Oct 2005

Fingerprint

beta-Thalassemia
Exercise
Hemoglobins
Anemia
Spleen
Exercise Test
Oxygen Consumption
Fatigue
Blood Proteins
Proteins

Keywords

  • Anaemia
  • Haemoglobin
  • Muscular deconditioning
  • Oxygen consumption
  • Spleen contraction

ASJC Scopus subject areas

  • Hematology

Cite this

Exercise capacity in patients with β-thalassaemia intermedia. / Agostoni, Piergiuseppe; Cerino, Mario; Palermo, Pietro; Magini, Alessandra; Bianchi, Michele; Bussotti, Maurizio; Fiorelli, Gemino; Cappellini, Maria D.

In: British Journal of Haematology, Vol. 131, No. 2, 10.2005, p. 278-281.

Research output: Contribution to journalArticle

@article{dd13da5eca0f403c8356cfe7492a7392,
title = "Exercise capacity in patients with β-thalassaemia intermedia",
abstract = "Thalassaemia intermedia patients can suffer fatigue and exercise capacity reduction, possibly because of anaemia, deconditioning and lack of exercise-induced haemoconcentration. We studied 21 β-thalassaemia intermedia patients, 10 splenectomised (group A) and 11 not splenectomised (group B). Patients were evaluated by cardiopulmonary exercise test with blood sampling for haemoglobin and plasma protein measurements at rest and peak. During exercise, an isolated increase of haemoglobin suggested spleen contraction while a parallel increase of haemoglobin and proteins suggested fluid filtration through capillary wall. Groups were homogeneous for age and gender. Peak oxygen consumption (VO2) was 22.5 ± 4.4 ml/min/kg (51 ± 14{\%}) and 24.3 ± 7.0 (53 ± 12{\%}) in groups A and B respectively [not significant (NS)]. At rest, haemoglobin was 8.8 g/dl in both groups. Exercise-induced increment was 0.4 ± 0.2 and 1.0 ± 0.4 g/dl (P <0.001) for haemoglobin and 4.0 ± 3.0 and 5.0 ± 4.0 g/l (NS) for proteins, in groups A and B respectively. Anaemia was the major cause of peak VO2 reduction (1097 ± 260 ml/min). However, anaemia did not explain the entire exercise capacity reduction, suggesting the presence of muscular deconditioning. Exercise capacity is reduced in β-thalassaemia intermedia because of anaemia and muscular deconditioning. Spleen contraction does not significantly influence exercise capacity although exercise-induced haemoconcentration was greater in patients with spleen.",
keywords = "Anaemia, Haemoglobin, Muscular deconditioning, Oxygen consumption, Spleen contraction",
author = "Piergiuseppe Agostoni and Mario Cerino and Pietro Palermo and Alessandra Magini and Michele Bianchi and Maurizio Bussotti and Gemino Fiorelli and Cappellini, {Maria D.}",
year = "2005",
month = "10",
doi = "10.1111/j.1365-2141.2005.05765.x",
language = "English",
volume = "131",
pages = "278--281",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "2",

}

TY - JOUR

T1 - Exercise capacity in patients with β-thalassaemia intermedia

AU - Agostoni, Piergiuseppe

AU - Cerino, Mario

AU - Palermo, Pietro

AU - Magini, Alessandra

AU - Bianchi, Michele

AU - Bussotti, Maurizio

AU - Fiorelli, Gemino

AU - Cappellini, Maria D.

PY - 2005/10

Y1 - 2005/10

N2 - Thalassaemia intermedia patients can suffer fatigue and exercise capacity reduction, possibly because of anaemia, deconditioning and lack of exercise-induced haemoconcentration. We studied 21 β-thalassaemia intermedia patients, 10 splenectomised (group A) and 11 not splenectomised (group B). Patients were evaluated by cardiopulmonary exercise test with blood sampling for haemoglobin and plasma protein measurements at rest and peak. During exercise, an isolated increase of haemoglobin suggested spleen contraction while a parallel increase of haemoglobin and proteins suggested fluid filtration through capillary wall. Groups were homogeneous for age and gender. Peak oxygen consumption (VO2) was 22.5 ± 4.4 ml/min/kg (51 ± 14%) and 24.3 ± 7.0 (53 ± 12%) in groups A and B respectively [not significant (NS)]. At rest, haemoglobin was 8.8 g/dl in both groups. Exercise-induced increment was 0.4 ± 0.2 and 1.0 ± 0.4 g/dl (P <0.001) for haemoglobin and 4.0 ± 3.0 and 5.0 ± 4.0 g/l (NS) for proteins, in groups A and B respectively. Anaemia was the major cause of peak VO2 reduction (1097 ± 260 ml/min). However, anaemia did not explain the entire exercise capacity reduction, suggesting the presence of muscular deconditioning. Exercise capacity is reduced in β-thalassaemia intermedia because of anaemia and muscular deconditioning. Spleen contraction does not significantly influence exercise capacity although exercise-induced haemoconcentration was greater in patients with spleen.

AB - Thalassaemia intermedia patients can suffer fatigue and exercise capacity reduction, possibly because of anaemia, deconditioning and lack of exercise-induced haemoconcentration. We studied 21 β-thalassaemia intermedia patients, 10 splenectomised (group A) and 11 not splenectomised (group B). Patients were evaluated by cardiopulmonary exercise test with blood sampling for haemoglobin and plasma protein measurements at rest and peak. During exercise, an isolated increase of haemoglobin suggested spleen contraction while a parallel increase of haemoglobin and proteins suggested fluid filtration through capillary wall. Groups were homogeneous for age and gender. Peak oxygen consumption (VO2) was 22.5 ± 4.4 ml/min/kg (51 ± 14%) and 24.3 ± 7.0 (53 ± 12%) in groups A and B respectively [not significant (NS)]. At rest, haemoglobin was 8.8 g/dl in both groups. Exercise-induced increment was 0.4 ± 0.2 and 1.0 ± 0.4 g/dl (P <0.001) for haemoglobin and 4.0 ± 3.0 and 5.0 ± 4.0 g/l (NS) for proteins, in groups A and B respectively. Anaemia was the major cause of peak VO2 reduction (1097 ± 260 ml/min). However, anaemia did not explain the entire exercise capacity reduction, suggesting the presence of muscular deconditioning. Exercise capacity is reduced in β-thalassaemia intermedia because of anaemia and muscular deconditioning. Spleen contraction does not significantly influence exercise capacity although exercise-induced haemoconcentration was greater in patients with spleen.

KW - Anaemia

KW - Haemoglobin

KW - Muscular deconditioning

KW - Oxygen consumption

KW - Spleen contraction

UR - http://www.scopus.com/inward/record.url?scp=32944466668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32944466668&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2005.05765.x

DO - 10.1111/j.1365-2141.2005.05765.x

M3 - Article

VL - 131

SP - 278

EP - 281

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -